These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19320847)

  • 1. siRNA-mediated knockdown of the heme synthesis and degradation pathways: modulation of treatment effect of 5-aminolevulinic acid-based photodynamic therapy in urothelial cancer cell lines.
    Miyake M; Ishii M; Kawashima K; Kodama T; Sugano K; Fujimoto K; Hirao Y
    Photochem Photobiol; 2009; 85(4):1020-7. PubMed ID: 19320847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of heme oxygenase-1 increases responsiveness of melanoma cells to ALA-based photodynamic therapy.
    Frank J; Lornejad-Schäfer MR; Schöffl H; Flaccus A; Lambert C; Biesalski HK
    Int J Oncol; 2007 Dec; 31(6):1539-45. PubMed ID: 17982681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Silencing Heme Biosynthesis Enzymes on 5-Aminolevulinic Acid-mediated Protoporphyrin IX Fluorescence and Photodynamic Therapy.
    Yang X; Li W; Palasuberniam P; Myers KA; Wang C; Chen B
    Photochem Photobiol; 2015; 91(4):923-30. PubMed ID: 25809721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 5-aminolevulinic acid-mediated photodynamic therapy on MCF-7 and MCF-7/ADR cells.
    Tsai T; Hong RL; Tsai JC; Lou PJ; Ling IF; Chen CT
    Lasers Surg Med; 2004; 34(1):62-72. PubMed ID: 14755426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility to 5-aminolevulinic acid based photodynamic therapy in WHO I meningioma cells corresponds to ferrochelatase activity.
    Hefti M; Holenstein F; Albert I; Looser H; Luginbuehl V
    Photochem Photobiol; 2011; 87(1):235-41. PubMed ID: 21073472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel development of 5-aminolevurinic acid (ALA) in cancer diagnoses and therapy.
    Ishizuka M; Abe F; Sano Y; Takahashi K; Inoue K; Nakajima M; Kohda T; Komatsu N; Ogura S; Tanaka T
    Int Immunopharmacol; 2011 Mar; 11(3):358-65. PubMed ID: 21144919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.
    Ohgari Y; Nakayasu Y; Kitajima S; Sawamoto M; Mori H; Shimokawa O; Matsui H; Taketani S
    Biochem Pharmacol; 2005 Dec; 71(1-2):42-9. PubMed ID: 16288996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of porphyrin and iron metabolisms in the δ-aminolevulinic acid (ALA)-induced accumulation of protoporphyrin and photodamage of tumor cells.
    Ohgari Y; Miyata Y; Miyagi T; Gotoh S; Ohta T; Kataoka T; Furuyama K; Taketani S
    Photochem Photobiol; 2011; 87(5):1138-45. PubMed ID: 21668870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of alloantigen-activated cells by aminolevulinic acid-based photodynamic therapy.
    Hryhorenko EA; Oseroff AR; Morgan J; Rittenhouse-Diakun K
    Photochem Photobiol; 1999 May; 69(5):560-5. PubMed ID: 10333761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular effectors and modulators of hypericin-mediated cell death in bladder cancer cells.
    Buytaert E; Matroule JY; Durinck S; Close P; Kocanova S; Vandenheede JR; de Witte PA; Piette J; Agostinis P
    Oncogene; 2008 Mar; 27(13):1916-29. PubMed ID: 17952126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALA-PDT results in phenotypic changes and decreased cellular invasion in surviving cancer cells.
    Tsai T; Ji HT; Chiang PC; Chou RH; Chang WS; Chen CT
    Lasers Surg Med; 2009 Apr; 41(4):305-15. PubMed ID: 19347942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation and proteomic changes on the heme pathway following treatment with 5-aminolevulinic acid.
    Sansaloni-Pastor S; Varesio E; Lange N
    J Photochem Photobiol B; 2022 Aug; 233():112484. PubMed ID: 35671620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model.
    Iinuma S; Bachor R; Flotte T; Hasan T
    J Urol; 1995 Mar; 153(3 Pt 1):802-6. PubMed ID: 7861543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of migratory activity and invasiveness of human glioma spheroids following 5-aminolevulinic acid-based photodynamic treatment. Laboratory investigation.
    Etminan N; Peters C; Ficnar J; Anlasik S; Bünemann E; Slotty PJ; Hänggi D; Steiger HJ; Sorg RV; Stummer W
    J Neurosurg; 2011 Aug; 115(2):281-8. PubMed ID: 21513432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
    Inoue K; Fukuhara H; Kurabayashi A; Furihata M; Tsuda M; Nagakawa K; Fujita H; Utsumi K; Shuin T
    Cancer Sci; 2013 Jun; 104(6):765-72. PubMed ID: 23480042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing of ferrochelatase enhances 5-aminolevulinic acid-based fluorescence and photodynamic therapy efficacy.
    Teng L; Nakada M; Zhao SG; Endo Y; Furuyama N; Nambu E; Pyko IV; Hayashi Y; Hamada JI
    Br J Cancer; 2011 Mar; 104(5):798-807. PubMed ID: 21304523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro resistance of articular chondrocytes to 5-Aminolevulinic acid based photodynamic therapy.
    Egli RJ; Di Criscio A; Hempfing A; Schoeniger R; Ganz R; Hofstetter W; Leunig M
    Lasers Surg Med; 2008 Apr; 40(4):282-90. PubMed ID: 18412230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive biomarkers for 5-ALA-PDT can lead to personalized treatments and overcome tumor-specific resistances.
    Mastrangelopoulou M; Grigalavicius M; Raabe TH; Skarpen E; Juzenas P; Peng Q; Berg K; Theodossiou TA
    Cancer Rep (Hoboken); 2022 Dec; 5(12):e1278. PubMed ID: 32737955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photodynamic therapy using direct-current pulsed iontophoresis for 5-aminolevulinic acid application.
    Mizutani K; Watanabe D; Akita Y; Akimoto M; Tamada Y; Matsumoto Y
    Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):280-2. PubMed ID: 19747250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of 5-aminolevulinic acid in photochemotherapy and fluorescence diagnostics].
    Moan J; Bech O; Peng Q; Berg K
    Tidsskr Nor Laegeforen; 1998 Mar; 118(8):1206-11. PubMed ID: 9567698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.